Side Effects of Pulmonary Hypertension Medications
Trial ID or NCT#
Status
Purpose
The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.
Official Title
Patient Reported Side Effects of Pulmonary Hypertension (PH) Medications
Eligibility Criteria
- - pulmonary hypertension - currently taking at least one of the following PH medications (Bosentan, Epoprostenol, Letairis, Sildenafil, Tadalafil, Treprostinil, Ventaris)
- - >18 years
Contact us to find out if this trial is right for you.
Contact
Jeffrey Feinstein, MD, MPH
650-723-7913
View on ClinicalTrials.gov